期刊文献+

双环醇治疗慢性乙型肝炎疗效分析

Clinical Analysis about Treatment of Chronic Hepatitis B with Bicyclol
暂未订购
导出
摘要 目的观察双环醇治疗慢性乙型肝炎的临床疗效。方法采用随机对照的方法,选择80例慢性乙型肝炎患者随机分为两组接受治疗,治疗组40例,每日服用双环醇片75mg;对照组40例,每日服用护肝片12片,均连续用药12周。观察治疗前后血清氨基转移酶水平。结果疗程结束两组血清氨基转移酶均下降,治疗组更为显著(P<0.05,P<0.01)。结论双环醇治疗慢性乙型肝炎生物学效应高,安全性好,值得临床推广应用。 Objective To observe clinical efficacy about the treatment of chronic hepatitis B with bicyclol. Methods A randomized controlled method, select 80 cases of chronic hepatitis B patients were randomly divided into 2 groups for treatment, 40 cases of treatment group, the daily intake bicyclol 75mg; the control group 40 cases, taking a daily tablet Hugan tablets 12 pills, are continuous medication for 12 weeks. Observed before and after treatment levels of serum aminotransferase. Result The end results of treatment 2, serum aminotransferase decreased, the treatment group significantly more (P〈0.05, P〈0.01). Conclusions Bicyclol treatment of chronic hepatitis B in biochemistry have made a better efficacy, and safety is good, easy to use, it is worthy of clinical application.
作者 禹萌 耿晓林
出处 《中国医药指南》 2010年第6期17-19,共3页 Guide of China Medicine
关键词 慢性乙型肝炎 双环醇 疗效 Chronic hepatitis B Bicyclol Efficacy
  • 相关文献

参考文献9

二级参考文献35

  • 1王建军,成军,刘妍,杨倩,纪冬,党晓燕,王春花.基因表达谱芯片筛选双环醇作用HepG2细胞后的差异表达基因[J].世界华人消化杂志,2004,12(7):1711-1714. 被引量:24
  • 2Liu GT, Zheng CZ, Li Y, et al. Clinical and pharmacological study of bicyclol-apotential anti chronic viral hepatitis drug[J]. Clin Med Sci J, 1999,14(1):51 -53.
  • 3Iredale JP, Benyon RC, Pickerlng J, et al, Mechanisms of spontaneous resolution of rat liver fibrosis, Hepatic stellate cell apotosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest, 1998,102:538-549.
  • 4Liu Gengtao, Zhang Chunzhen ,Li Yan, et al. Clinical and pharmacological study of Bieyelol-A potential anti-chronic vital hepatitis drug. Chin Med Sci J,1999,14(supple) :s51-s53.
  • 5Chevallier M, Guerret S, Chossegros P, et al. A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: comparison with morphonetric studies. Hepatol, 1994,20:349-355.
  • 6Housset C, Guechot J. Hepatic fibrosis:physiopathology and biological diagnosis. Pathol Biol, 1999,47:886-899.
  • 7Korner T, Kropf J, Gressner AM. Serum laminin and hyaluronan in liver cirrhosis:markers of progression with high prognostic value. J Hepatol,1996,25:684-688.
  • 8Milich DR. Influence of T-helper cell subsets and crossregulation in hepatitis B virus infection[J]. J Virol Hepatol, 1997, 4(2): 248-59.
  • 9O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets [ J ]. Immunity, 1998, 8(3): 275-83.
  • 10Bertoletti A, Maini MK. Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C virus[J ]. Curr Opin Immunol, 2000, 12(4): 403-8.

共引文献14227

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部